Discover how the cancer drug 5-aza-2'-deoxycytidine's toxicity comes from DNA methyltransferase trapping rather than DNA demethylation, reshaping epigenetic therapy approaches.
Discover how bioorthogonal chemistry and diazirine-based probes are revolutionizing epigenetic research by revealing DNA's hidden modifications.
Discover how LEM-06, the first NSD2 inhibitor, is revolutionizing epigenetic cancer therapy and offering new hope for multiple myeloma patients.
Revolutionary biosensor combining glowing rare-earth polymers and DNA domino circuits for precise detection of m6A RNA modifications.